Cell2Cure
Phase 1Cell to Cure develops clinical-stage stem cell therapies using allogeneic adipose-derived mesenchymal cells for unmet medical needs.
Founded
2015
Focus
Cell & Gene Therapy
About
Cell to Cure develops clinical-stage stem cell therapies using allogeneic adipose-derived mesenchymal cells for unmet medical needs.
Funding History
2Total raised: $21M
Series A$18MUndisclosedJul 15, 2022
Seed$3MUndisclosedNov 15, 2019
Company Info
TypePrivate
Founded2015
LocationCopenhagen, Denmark
StagePhase 1
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile